Skip to Content
Merck
CN
  • Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization.

Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization.

Autophagy (2016-11-02)
Sonia Hernández-Tiedra, Gemma Fabriàs, David Dávila, Íñigo J Salanueva, Josefina Casas, L Ruth Montes, Zuriñe Antón, Elena García-Taboada, María Salazar-Roa, Mar Lorente, Jesper Nylandsted, Jane Armstrong, Israel López-Valero, Christopher S McKee, Ana Serrano-Puebla, Roberto García-López, José González-Martínez, José L Abad, Kentaro Hanada, Patricia Boya, Félix Goñi, Manuel Guzmán, Penny Lovat, Marja Jäättelä, Alicia Alonso, Guillermo Velasco
ABSTRACT

Autophagy is considered primarily a cell survival process, although it can also lead to cell death. However, the factors that dictate the shift between these 2 opposite outcomes remain largely unknown. In this work, we used Δ9-tetrahydrocannabinol (THC, the main active component of marijuana, a compound that triggers autophagy-mediated cancer cell death) and nutrient deprivation (an autophagic stimulus that triggers cytoprotective autophagy) to investigate the precise molecular mechanisms responsible for the activation of cytotoxic autophagy in cancer cells. By using a wide array of experimental approaches we show that THC (but not nutrient deprivation) increases the dihydroceramide:ceramide ratio in the endoplasmic reticulum of glioma cells, and this alteration is directed to autophagosomes and autolysosomes to promote lysosomal membrane permeabilization, cathepsin release and the subsequent activation of apoptotic cell death. These findings pave the way to clarify the regulatory mechanisms that determine the selective activation of autophagy-mediated cancer cell death.

MATERIALS
Product Number
Brand
Product Description

Avanti
12:0 SM (d18:1/12:0), Avanti Polar Lipids 860583P, powder
Avanti
Cholesterol (ovine), Avanti Polar Lipids
Sigma-Aldrich
Anti-Cathepsin B (Ab-1) Mouse mAb (CA10), lyophilized, clone CA10, Calbiochem®
Sigma-Aldrich
meso-Tetraphenylporphyrin, BioReagent, suitable for fluorescence, ≥99.0% (HPLC)
Sigma-Aldrich
Anti-LC3B antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
1,10-Phenanthroline, ≥99%
Sigma-Aldrich
Glutaraldehyde solution, 50 wt. % in H2O
Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-15, ascites fluid
Sigma-Aldrich
Glycine, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Paraformaldehyde, reagent grade, crystalline
Avanti
16:0-18:1 PC, Avanti Polar Lipids
Avanti
Egg SM, Avanti Polar Lipids
Avanti
Egg PC, Avanti Polar Lipids
Avanti
Egg SM, Avanti Polar Lipids
Avanti
16:0-18:1 PC, Avanti Polar Lipids
Avanti
Egg PC, Avanti Polar Lipids
Sigma-Aldrich
p-Xylene-bis(N-pyridinium bromide), ≥95% (TLC)
Sigma-Aldrich
Sphingomyelinase from Bacillus cereus, lyophilized powder, ≥100 units/mg protein
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Monoclonal Anti-α-Tubulin antibody produced in mouse, clone DM1A, ascites fluid
Sigma-Aldrich
TRI Reagent®, For processing tissues, cells cultured in monolayer or cell pellets
Sigma-Aldrich
Anti-TGN46 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Avanti
C12 Ceramide (d18:1/12:0), Avanti Polar Lipids
Avanti
C16 Dihydroceramide (d18:0/16:0), Avanti Polar Lipids 860634P, powder